(~60 sites worldwide to be activated) Please refer to current list on clinicaltrials.gov.

United Kingdom sites (all recruiting soon):

• Aberdeen - Aberdeen Royal Infirmary, Foresterhill Health Campus, Foresterhill Rd, Aberdeen AB25 2ZN
• Birmingham - Queen Elizabeth Hospital, Mindelsohn Way, Birmingham, B15 2TH
• Camberley - Frimley Park Hospital, Portsmouth Rd, Frimley, Camberley GU16 7UJ
• Glasgow - Glasgow Royal Infirmary, 4 Alexandra Parade, Glasgow G31 2ET
• Hull - Hull Royal Infirmary, Anlaby Rd, Hull HU3 2JZ
• London
  • Royal Free, Pond St, Hampstead, London NW3 2QG
    London
  • Royal London Hospital, Whitechapel, London, Greater London E1 1BB

If you think you are eligible (suitable) and you want to take part but your hospital is not running the trial, it is still possible to take part.

Talk to your PSC doctor or contact the nearest study site to you. Some people switch hospitals  temporarily for the duration of the clinical trial so that their PSC care and clinical trial study visits are at the same hospital; or they have a  'shared care' agreement whereby they still see their regular hospital doctor but also the PSC specialist who is running the clinical trial. Most PSC doctors will be supportive and coordinate this for you.

Please get in touch with Martine at hello@pscsupport.org.uk if you need help joining a clinical trial at a different hospital.

ELMWOOD is investigating a drug called 'Elafibranor'. It is an investigational drug that is taken by mouth. It activates specific receptors (PPARα/δ) in the human body, particularly in the liver^1,2. Activation of these receptors is thought to have different effects, including reduced inflammation and improvement of bile acid composition and flow³.

People who take part will have blood tests, electrocardiogram, ultrasound scans, Transient Elastography (FibroScan®), and questionnaires to complete etc.

Every clinical trial sets out strict rules defining who can and can't take part. Find out in the KEY INFORMATION if you are likely to be eligible.